nach oben

Erschienen in:

24.08.2022

The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer

verfasst von: Bruce A. Bunnell, Elizabeth C. Martin, Margarite D. Matossian, Courtney K. Brock, Khoa Nguyen, Bridgette Collins-Burow, Matthew E. Burow

Erschienen in: Cancer and Metastasis Reviews | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

The significant increase in the incidence of obesity represents the next global health crisis. As a result, scientific research has focused on gaining deeper insights into obesity and adipose tissue biology. As a result of the excessive accumulation of adipose tissue, obesity results from hyperplasia and hypertrophy within the adipose tissue. The functional alterations in the adipose tissue are a confounding contributing factor to many diseases, including cancer. The increased incidence and aggressiveness of several cancers, including colorectal, postmenopausal breast, endometrial, prostate, esophageal, hematological, malignant melanoma, and renal carcinomas, result from obesity as a contributing factor. The increased morbidity and mortality of obesity-associated cancers are attributable to increased hormones, adipokines, and cytokines produced by the adipose tissue. The increased adipose tissue levels observed in obese patients result in more adipose stromal/stem cells (ASCs) distributed throughout the body. ASCs have been shown to impact cancer progression in vitro and in preclinical animal models. ASCs influence tumor biology via multiple mechanisms, including the increased recruitment of ASCs to the tumor site and increased production of cytokines and growth factors by ASCs and other cells within the tumor stroma. Emerging evidence indicates that obesity induces alterations in the biological properties of ASCs, subsequently leading to enhanced tumorigenesis and metastasis of cancer cells. As the focus of this review is the interaction and impact of ASCs on cancer, the presentation is limited to preclinical data generated on cancers in which there is a demonstrated role for ASCs, such as postmenopausal breast, colorectal, prostate, ovarian, multiple myeloma, osteosarcoma, cervical, bladder, and gastrointestinal cancers. Our group has investigated the interactions between obesity and breast cancer and the mechanisms that regulate ASCs and adipocytes in these different contexts through interactions between cancer cells, immune cells, and other cell types present in the tumor microenvironment (TME) are discussed. The reciprocal and circular feedback loop between obesity and ASCs and the mechanisms by which ASCs from obese patients alter the biology of cancer cells and enhance tumorigenesis will be discussed. At present, the evidence for ASCs directly influencing human tumor growth is somewhat limited, though recent clinical studies suggest there may be some link.

Zwick, R. K., Guerrero-Juarez, C. F., Horsley, V., & Plikus, M. V. (2018). Anatomical, physiological, and functional diversity of adipose tissue. Cell Metabolism, 27(1), 68–83. https://doi.org/10.1016/j.cmet.2017.12.002CrossRefPubMedPubMedCentral

Harvey, I., Boudreau, A., & Stephens, J. M. (2020). Adipose tissue in health and disease. Open Biology, 10(12), 200291. https://doi.org/10.1098/rsob.200291CrossRefPubMedPubMedCentral

Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature, 372(6505), 425–432. https://doi.org/10.1038/372425a0CrossRefPubMed

Friedman, J. (2014). 20 years of leptin: Leptin at 20: An overview. Journal of Endocrinology, 223(1), T1-8. https://doi.org/10.1530/joe-14-0405CrossRefPubMed

Caër, C., Rouault, C., Le Roy, T., Poitou, C., Aron-Wisnewsky, J., Torcivia, A., et al. (2017). Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue. Science and Reports, 7(1), 3000. https://doi.org/10.1038/s41598-017-02660-wCrossRef

Coppack, S. W. (2001). Pro-inflammatory cytokines and adipose tissue. Proceedings of the Nutrition Society 60(3):349-356 https://doi.org/10.1079/pns2001110

Frayn, K. N., Arner, P., & Yki-Järvinen, H. (2006). Fatty acid metabolism in adipose tissue, muscle and liver in health and disease. Essays in Biochemistry, 42, 89–103. https://doi.org/10.1042/bse0420089CrossRefPubMed

Klingenberg, M. (1990). Mechanism and evolution of the uncoupling protein of brown adipose tissue. Trends in Biochemical Sciences, 15(3), 108–112. https://doi.org/10.1016/0968-0004(90)90194-gCrossRefPubMed

Puigserver, P., Herron, D., Gianotti, M., Palou, A., Cannon, B., & Nedergaard, J. (1992). Induction and degradation of the uncoupling protein thermogenin in brown adipocytes in vitro and in vivo. Evidence for a rapidly degradable pool. Biochem Journal, 284(Pt 2), 393–398.CrossRef

10.

Seale, P., Bjork, B., Yang, W., Kajimura, S., Chin, S., Kuang, S., et al. (2008). PRDM16 controls a brown fat/skeletal muscle switch. Nature, 454(7207), 961–967. https://doi.org/10.1038/nature07182CrossRefPubMedPubMedCentral

11.

Seale, P., Conroe, H. M., Estall, J., Kajimura, S., Frontini, A., Ishibashi, J., et al. (2011). Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. The Journal of Clinical Investigation, 121(1), 96–105. https://doi.org/10.1172/jci44271CrossRefPubMed

12.

Wang, W., & Seale, P. (2016). Control of brown and beige fat development. Nature Reviews Molecular Cell Biology, 17(11), 691–702. https://doi.org/10.1038/nrm.2016.96CrossRefPubMedPubMedCentral

13.

Wu, J., Boström, P., Sparks, L. M., Ye, L., Choi, J. H., Giang, A. H., et al. (2012). Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell, 150(2), 366–376. https://doi.org/10.1016/j.cell.2012.05.016CrossRefPubMedPubMedCentral

14.

Harms, M., & Seale, P. (2013). Brown and beige fat: Development, function and therapeutic potential. Nature Medicine, 19(10), 1252–1263. https://doi.org/10.1038/nm.3361CrossRefPubMed

15.

Pilkington, A. C., Paz, H. A., & Wankhade, U. D. (2021). Beige adipose tissue identification and marker specificity-overview. Front Endocrinol (Lausanne), 12, 599134. https://doi.org/10.3389/fendo.2021.599134CrossRef

16.

Sidossis, L., & Kajimura, S. (2015). Brown and beige fat in humans: Thermogenic adipocytes that control energy and glucose homeostasis. The Journal of Clinical Investigation, 125(2), 478–486. https://doi.org/10.1172/jci78362CrossRefPubMedPubMedCentral

17.

Uccelli, A., Moretta, L., & Pistoia, V. (2008). Mesenchymal stem cells in health and disease. Nature Reviews Immunology, 8(9), 726–736. https://doi.org/10.1038/nri2395CrossRefPubMed

18.

Galipeau, J., & Sensébé, L. (2018). Mesenchymal stromal cells: Clinical challenges and therapeutic opportunities. Cell Stem Cell, 22(6), 824–833. https://doi.org/10.1016/j.stem.2018.05.004CrossRefPubMedPubMedCentral

19.

Bunnell, B. A. (2021). Adipose tissue-derived mesenchymal stem cells. Cells, 10(12), 3433. https://doi.org/10.3390/cells10123433CrossRefPubMedPubMedCentral

20.

Prockop, D. J., & Oh, J. Y. (2012). Mesenchymal stem/stromal cells (MSCs): Role as guardians of inflammation. Molecular Therapy, 20(1), 14–20. https://doi.org/10.1038/mt.2011.211CrossRefPubMed

21.

Regulski, M. J. (2017). Mesenchymal stem cells: “Guardians of Inflammation.” Wounds, 29(1), 20–27.PubMed

22.

Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., et al. (2001). Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Engineering, 7(2), 211–228. https://doi.org/10.1089/107632701300062859CrossRefPubMed

23.

Fukuchi, Y., Nakajima, H., Sugiyama, D., Hirose, I., Kitamura, T., & Tsuji, K. (2004). Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells, 22(5), 649–658. https://doi.org/10.1634/stemcells.22-5-649CrossRefPubMed

24.

Troyer, D. L., & Weiss, M. L. (2008). Wharton’s jelly-derived cells are a primitive stromal cell population. Stem Cells, 26(3), 591–599. https://doi.org/10.1634/stemcells.2007-0439CrossRefPubMed

25.

Huang, G. T., Gronthos, S., & Shi, S. (2009). Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. Journal of Dental Research, 88(9), 792–806. https://doi.org/10.1177/0022034509340867CrossRefPubMedPubMedCentral

26.

Bourin, P., Bunnell, B. A., Casteilla, L., Dominici, M., Katz, A. J., March, K. L., et al. (2013). Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy, 15(6), 641–648. https://doi.org/10.1016/j.jcyt.2013.02.006CrossRefPubMedPubMedCentral

27.

Gonzalez-Rey, E., Gonzalez, M. A., Varela, N., O’Valle, F., Hernandez-Cortes, P., Rico, L., et al. (2010). Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Annals of the Rheumatic Diseases, 69(1), 241–248. https://doi.org/10.1136/ard.2008.101881CrossRefPubMed

28.

Semon, J. A., Maness, C., Zhang, X., Sharkey, S. A., Beuttler, M. M., Shah, F. S., et al. (2014). Comparison of human adult stem cells from adipose tissue and bone marrow in the treatment of experimental autoimmune encephalomyelitis. Stem Cell Research & Therapy, 5(1), 2. https://doi.org/10.1186/scrt391CrossRef

29.

Zhang, S., Danchuk, S. D., Bonvillain, R. W., Xu, B., Scruggs, B. A., Strong, A. L., et al. (2014). Interleukin 6 mediates the therapeutic effects of adipose-derived stromal/stem cells in lipopolysaccharide-induced acute lung injury. Stem Cells, 32(6), 1616–1628. https://doi.org/10.1002/stem.1632CrossRefPubMed

30.

Luque-Campos, N., Contreras-López, R. A., Jose Paredes-Martínez, M., Torres, M. J., Bahraoui, S., Wei, M., et al. (2019). Mesenchymal Stem cells improve rheumatoid arthritis progression by controlling memory T cell response. Frontiers in Immunology, 10, 798. https://doi.org/10.3389/fimmu.2019.00798CrossRefPubMedPubMedCentral

31.

Jiang, W., & Xu, J. (2020). Immune modulation by mesenchymal stem cells. Cell Proliferation, 53(1), e12712. https://doi.org/10.1111/cpr.12712CrossRefPubMed

32.

Le Blanc, K., Tammik, L., Sundberg, B., Haynesworth, S. E., & Ringdén, O. (2003). Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scandinavian Journal of Immunology, 57(1), 11–20. https://doi.org/10.1046/j.1365-3083.2003.01176.xCrossRefPubMed

33.

Krampera, M., Cosmi, L., Angeli, R., Pasini, A., Liotta, F., Andreini, A., et al. (2006). Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells, 24(2), 386–398. https://doi.org/10.1634/stemcells.2005-0008CrossRefPubMed

34.

Batten, P., Sarathchandra, P., Antoniw, J. W., Tay, S. S., Lowdell, M. W., Taylor, P. M., et al. (2006). Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: Relevance to tissue engineering human heart valves. Tissue Engineering, 12(8), 2263–2273. https://doi.org/10.1089/ten.2006.12.2263CrossRefPubMed

35.

Le Blanc, K., Samuelsson, H., Lönnies, L., Sundin, M., & Ringdén, O. (2007). Generation of immunosuppressive mesenchymal stem cells in allogeneic human serum. Transplantation, 84(8), 1055–1059. https://doi.org/10.1097/01.tp.0000285088.44901.eaCrossRefPubMed

36.

Selmani, Z., Naji, A., Zidi, I., Favier, B., Gaiffe, E., Obert, L., et al. (2008). Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells, 26(1), 212–222. https://doi.org/10.1634/stemcells.2007-0554CrossRefPubMed

37.

Bochev, I., Elmadjian, G., Kyurkchiev, D., Tzvetanov, L., Altankova, I., Tivchev, P., et al. (2008). Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biology International, 32(4), 384–393. https://doi.org/10.1016/j.cellbi.2007.12.007CrossRefPubMed

38.

Asari, S., Itakura, S., Ferreri, K., Liu, C. P., Kuroda, Y., Kandeel, F., et al. (2009). Mesenchymal stem cells suppress B-cell terminal differentiation. Experimental Hematology, 37(5), 604–615. https://doi.org/10.1016/j.exphem.2009.01.005CrossRefPubMedPubMedCentral

39.

DelaRosa, O., Sánchez-Correa, B., Morgado, S., Ramírez, C., del Río, B., Menta, R., et al. (2012). Human adipose-derived stem cells impair natural killer cell function and exhibit low susceptibility to natural killer-mediated lysis. Stem Cells Dev, 21(8), 1333–1343. https://doi.org/10.1089/scd.2011.0139CrossRefPubMed

40.

Spaggiari, G. M., Capobianco, A., Becchetti, S., Mingari, M. C., & Moretta, L. (2006). Mesenchymal stem cell-natural killer cell interactions: Evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood, 107(4), 1484–1490. https://doi.org/10.1182/blood-2005-07-2775CrossRefPubMed

41.

Spaggiari, G. M., Capobianco, A., Abdelrazik, H., Becchetti, F., Mingari, M. C., & Moretta, L. (2008). Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: Role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood, 111(3), 1327–1333. https://doi.org/10.1182/blood-2007-02-074997CrossRefPubMed

42.

Geng, Y., Zhang, L., Fu, B., Zhang, J., Hong, Q., Hu, J., et al. (2014). Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages. Stem Cell Research & Therapy, 5(3), 80. https://doi.org/10.1186/scrt469CrossRef

43.

Song, W. J., Li, Q., Ryu, M. O., Ahn, J. O., Ha Bhang, D., Chan Jung, Y., et al. (2017). TSG-6 secreted by human adipose tissue-derived mesenchymal stem cells ameliorates DSS-induced colitis by inducing M2 macrophage polarization in Mice. Science and Reports, 7(1), 5187. https://doi.org/10.1038/s41598-017-04766-7CrossRef

44.

Traktuev, D. O., Merfeld-Clauss, S., Li, J., Kolonin, M., Arap, W., Pasqualini, R., et al. (2008). A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circulation Research, 102(1), 77–85. https://doi.org/10.1161/circresaha.107.159475CrossRefPubMed

45.

Suga, H., Matsumoto, D., Eto, H., Inoue, K., Aoi, N., Kato, H., et al. (2009). Functional implications of CD34 expression in human adipose-derived stem/progenitor cells. Stem Cells Dev, 18(8), 1201–1210. https://doi.org/10.1089/scd.2009.0003CrossRefPubMed

46.

Weiss, M. L., Anderson, C., Medicetty, S., Seshareddy, K. B., Weiss, R. J., VanderWerff, I., et al. (2008). Immune properties of human umbilical cord Wharton’s jelly-derived cells. Stem Cells, 26(11), 2865–2874. https://doi.org/10.1634/stemcells.2007-1028CrossRefPubMed

47.

Sousa, B. R., Parreira, R. C., Fonseca, E. A., Amaya, M. J., Tonelli, F. M., Lacerda, S. M., et al. (2014). Human adult stem cells from diverse origins: An overview from multiparametric immunophenotyping to clinical applications. Cytometry Part A, 85(1), 43–77. https://doi.org/10.1002/cyto.a.22402CrossRef

48.

Fogelholm, M. (2010). Physical activity, fitness and fatness: Relations to mortality, morbidity and disease risk factors A systematic review. Obes Rev, 11(3), 202–221. https://doi.org/10.1111/j.1467-789X.2009.00653.xCrossRefPubMed

49.

Doyle, S. L., Donohoe, C. L., Lysaght, J., & Reynolds, J. V. (2012). Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proceeding of Nutrition Society 71(1):181-189 https://doi.org/10.1017/s002966511100320x

50.

Pérez-Hernández, A. I., Catalán, V., Gómez-Ambrosi, J., Rodríguez, A., & Frühbeck, G. (2014). Mechanisms linking excess adiposity and carcinogenesis promotion. Front Endocrinol (Lausanne), 5, 65. https://doi.org/10.3389/fendo.2014.00065CrossRef

51.

Bianchini, F., Kaaks, R., & Vainio, H. (2002). Overweight, obesity, and cancer risk. The lancet Oncology, 3(9), 565–574. https://doi.org/10.1016/s1470-2045(02)00849-5CrossRefPubMed

52.

Caldwell, S. H., Crespo, D. M., Kang, H. S., & Al-Osaimi, A. M. (2004). Obesity and hepatocellular carcinoma. Gastroenterology, 127(5 Suppl 1), S97-103. https://doi.org/10.1053/j.gastro.2004.09.021CrossRefPubMed

53.

Buschemeyer, W. C., 3rd., & Freedland, S. J. (2007). Obesity and prostate cancer: Epidemiology and clinical implications. European Urology, 52(2), 331–343. https://doi.org/10.1016/j.eururo.2007.04.069CrossRefPubMed

54.

Giovannucci, E., & Michaud, D. (2007). The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology, 132(6), 2208–2225. https://doi.org/10.1053/j.gastro.2007.03.050CrossRefPubMed

55.

Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008). Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet, 371(9612), 569–578. https://doi.org/10.1016/s0140-6736(08)60269-xCrossRefPubMed

56.

Fader, A. N., Arriba, L. N., Frasure, H. E., & von Gruenigen, V. E. (2009). Endometrial cancer and obesity: Epidemiology, biomarkers, prevention and survivorship. Gynecologic Oncology, 114(1), 121–127. https://doi.org/10.1016/j.ygyno.2009.03.039CrossRefPubMed

57.

Reeves, K. W., Carter, G. C., Rodabough, R. J., Lane, D., McNeeley, S. G., Stefanick, M. L., et al. (2011). Obesity in relation to endometrial cancer risk and disease characteristics in the Women’s Health Initiative. Gynecologic Oncology, 121(2), 376–382. https://doi.org/10.1016/j.ygyno.2011.01.027CrossRefPubMedPubMedCentral

58.

Crosbie, E. J., Roberts, C., Qian, W., Swart, A. M., Kitchener, H. C., & Renehan, A. G. (2012). Body mass index does not influence post-treatment survival in early stage endometrial cancer: Results from the MRC ASTEC trial. European Journal of Cancer, 48(6), 853–864. https://doi.org/10.1016/j.ejca.2011.10.003CrossRefPubMed

59.

Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016). Body fatness and cancer–Viewpoint of the IARC working group. New England Journal of Medicine, 375(8), 794–798. https://doi.org/10.1056/NEJMsr1606602CrossRefPubMed

60.

Litton, J. K., Gonzalez-Angulo, A. M., Warneke, C. L., Buzdar, A. U., Kau, S. W., Bondy, M., et al. (2008). Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. Journal of Clinical Oncology, 26(25), 4072–4077. https://doi.org/10.1200/jco.2007.14.4527CrossRefPubMedPubMedCentral

61.

Sánchez, L., Lana, A., Hidalgo, A., Rodríguez, J. M., Del Valle Mdel, O., Cueto, A., et al. (2008). Risk factors for second primary tumours in breast cancer survivors. European Journal of Cancer Prevention, 17(5), 406–413. https://doi.org/10.1097/CEJ.0b013e3282f75ee5CrossRefPubMed

62.

Niraula, S., Ocana, A., Ennis, M., & Goodwin, P. J. (2012). Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: A meta-analysis. Breast Cancer Research and Treatment, 134(2), 769–781. https://doi.org/10.1007/s10549-012-2073-xCrossRefPubMed

63.

Petrelli, J. M., Calle, E. E., Rodriguez, C., & Thun, M. J. (2002). Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes and Control, 13(4), 325–332. https://doi.org/10.1023/a:1015288615472CrossRefPubMed

64.

Schapira, D. V., Kumar, N. B., Lyman, G. H., & Cox, C. E. (1990). Abdominal obesity and breast cancer risk. Annals of Internal Medicine, 112(3), 182–186. https://doi.org/10.7326/0003-4819-112-3-182CrossRefPubMed

65.

Abrahamson, P. E., Gammon, M. D., Lund, M. J., Flagg, E. W., Porter, P. L., Stevens, J., et al. (2006). General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiology, Biomarkers & Prevention, 15(10), 1871–1877. https://doi.org/10.1158/1055-9965.Epi-06-0356CrossRef

66.

Protani, M., Coory, M., & Martin, J. H. (2010). Effect of obesity on survival of women with breast cancer: Systematic review and meta-analysis. Breast Cancer Research and Treatment, 123(3), 627–635. https://doi.org/10.1007/s10549-010-0990-0CrossRefPubMed

67.

Fortner, R. T., Katzke, V., Kühn, T., & Kaaks, R. (2016). Obesity and breast cancer. Recent Results in Cancer Research, 208, 43–65. https://doi.org/10.1007/978-3-319-42542-9_3CrossRefPubMed

68.

Carmichael, A. R. (2006). Obesity and prognosis of breast cancer. Obesity Reviews, 7(4), 333–340. https://doi.org/10.1111/j.1467-789X.2006.00261.xCrossRefPubMed

69.

Sestak, I., Distler, W., Forbes, J. F., Dowsett, M., Howell, A., & Cuzick, J. (2010). Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: An exploratory analysis from the ATAC trial. Journal of Clinical Oncology, 28(21), 3411–3415. https://doi.org/10.1200/jco.2009.27.2021CrossRefPubMed

70.

Kumar, N. B., Cantor, A., Allen, K., & Cox, C. E. (2000). Android obesity at diagnosis and breast carcinoma survival: Evaluation of the effects of anthropometric variables at diagnosis, including body composition and body fat distribution and weight gain during life span, and survival from breast carcinoma. Cancer, 88(12), 2751–2757. https://doi.org/10.1002/1097-0142(20000615)88:12%3c2751::aid-cncr13%3e3.0.co;2-1CrossRefPubMed

71.

Borugian, M. J., Sheps, S. B., Kim-Sing, C., Olivotto, I. A., Van Patten, C., Dunn, B. P., et al. (2003). Waist-to-hip ratio and breast cancer mortality. American Journal of Epidemiology, 158(10), 963–968. https://doi.org/10.1093/aje/kwg236CrossRefPubMed

72.

Iwase, T., Wang, X., Shrimanker, T. V., Kolonin, M. G., & Ueno, N. T. (2021). Body composition and breast cancer risk and treatment: Mechanisms and impact. Breast Cancer Research and Treatment, 186(2), 273–283. https://doi.org/10.1007/s10549-020-06092-5CrossRefPubMed

73.

Harris, A. L. (2002). Hypoxia–A key regulatory factor in tumour growth. Nature Reviews Cancer, 2(1), 38–47. https://doi.org/10.1038/nrc704CrossRefPubMed

74.

Brahimi-Horn, M. C., & Pouysségur, J. (2007). Hypoxia in cancer cell metabolism and pH regulation. Essays in Biochemistry, 43, 165–178. https://doi.org/10.1042/bse0430165CrossRefPubMed

75.

Folkman, J., Hahnfeldt, P., & Hlatky, L. (2000). Cancer: Looking outside the genome. Nature Reviews Molecular Cell Biology, 1(1), 76–79. https://doi.org/10.1038/35036100CrossRefPubMed

76.

Blaak, E. E., van Baak, M. A., Kemerink, G. J., Pakbiers, M. T., Heidendal, G. A., & Saris, W. H. (1995). Beta-adrenergic stimulation and abdominal subcutaneous fat blood flow in lean, obese, and reduced-obese subjects. Metabolism, 44(2), 183–187. https://doi.org/10.1016/0026-0495(95)90262-7CrossRefPubMed

77.

Jansson, P. A., Larsson, A., & Lönnroth, P. N. (1998). Relationship between blood pressure, metabolic variables and blood flow in obese subjects with or without non-insulin-dependent diabetes mellitus. European Journal of Clinical Investigation, 28(10), 813–818. https://doi.org/10.1046/j.1365-2362.1998.00360.xCrossRefPubMed

78.

West, D. B., Prinz, W. A., Francendese, A. A., & Greenwood, M. R. (1987). Adipocyte blood flow is decreased in obese Zucker rats. American Journal of Physiology, 253(2 Pt 2), R228-233. https://doi.org/10.1152/ajpregu.1987.253.2.R228CrossRefPubMed

79.

Carroll, V. A., & Ashcroft, M. (2005). Targeting the molecular basis for tumour hypoxia. Expert Reviews in Molecular Medicine, 7(6), 1–16. https://doi.org/10.1017/s1462399405009117CrossRefPubMed

80.

Trayhurn, P. (2013). Hypoxia and adipose tissue function and dysfunction in obesity. Physiological Reviews, 93(1), 1–21. https://doi.org/10.1152/physrev.00017.2012CrossRefPubMed

81.

Zhang, Y., Daquinag, A. C., Amaya-Manzanares, F., Sirin, O., Tseng, C., & Kolonin, M. G. (2012). Stromal progenitor cells from endogenous adipose tissue contribute to pericytes and adipocytes that populate the tumor microenvironment. Cancer Research, 72(20), 5198–5208. https://doi.org/10.1158/0008-5472.Can-12-0294CrossRefPubMed

82.

Bellows, C. F., Zhang, Y., Chen, J., Frazier, M. L., & Kolonin, M. G. (2011). Circulation of progenitor cells in obese and lean colorectal cancer patients. Cancer Epidemiology, Biomarkers & Prevention, 20(11), 2461–2468. https://doi.org/10.1158/1055-9965.Epi-11-0556CrossRef

83.

Bellows, C. F., Zhang, Y., Simmons, P. J., Khalsa, A. S., & Kolonin, M. G. (2011). Influence of BMI on level of circulating progenitor cells. Obesity (Silver Spring), 19(8), 1722–1726. https://doi.org/10.1038/oby.2010.347CrossRef

84.

Strong, A. L., Semon, J. A., Strong, T. A., Santoke, T. T., Zhang, S., McFerrin, H. E., et al. (2012). Obesity-associated dysregulation of calpastatin and MMP-15 in adipose-derived stromal cells results in their enhanced invasion. Stem Cells, 30(12), 2774–2783. https://doi.org/10.1002/stem.1229CrossRefPubMed

85.

Gealekman, O., Guseva, N., Hartigan, C., Apotheker, S., Gorgoglione, M., Gurav, K., et al. (2011). Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation, 123(2), 186–194. https://doi.org/10.1161/circulationaha.110.970145CrossRefPubMedPubMedCentral

86.

Strong, A. L., Strong, T. A., Rhodes, L. V., Semon, J. A., Zhang, X., Shi, Z., et al. (2013). Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways. Breast Cancer Research, 15(5), R102. https://doi.org/10.1186/bcr3569CrossRefPubMedPubMedCentral

87.

Sabol, R. A., Giacomelli, P., Beighley, A., & Bunnell, B. A. (2019). Adipose stem cells and cancer: Concise review. Stem Cells, 37(10), 1261–1266. https://doi.org/10.1002/stem.3050CrossRefPubMed

88.

Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646–674. https://doi.org/10.1016/j.cell.2011.02.013CrossRefPubMed

89.

Karagiannis, G. S., Poutahidis, T., Erdman, S. E., Kirsch, R., Riddell, R. H., & Diamandis, E. P. (2012). Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue. Molecular Cancer Research, 10(11), 1403–1418. https://doi.org/10.1158/1541-7786.Mcr-12-0307CrossRefPubMed

90.

Strong, A. L., Pei, D. T., Hurst, C. G., Gimble, J. M., Burow, M. E., & Bunnell, B. A. (2017). Obesity enhances the conversion of adipose-derived stromal/stem cells into carcinoma-associated fibroblast leading to cancer cell proliferation and progression to an invasive phenotype. Stem Cells Int, 2017, 9216502. https://doi.org/10.1155/2017/9216502CrossRefPubMedPubMedCentral

91.

Plaks, V., Boldajipour, B., Linnemann, J. R., Nguyen, N. H., Kersten, K., Wolf, Y., et al. (2015). Adaptive immune regulation of mammary postnatal organogenesis. Developmental Cell, 34(5), 493–504. https://doi.org/10.1016/j.devcel.2015.07.015CrossRefPubMedPubMedCentral

92.

Liu, T., Han, C., Wang, S., Fang, P., Ma, Z., Xu, L., et al. (2019). Cancer-associated fibroblasts: An emerging target of anti-cancer immunotherapy. Journal of Hematology & Oncology, 12(1), 86. https://doi.org/10.1186/s13045-019-0770-1CrossRef

93.

Mariman, E. C., & Wang, P. (2010). Adipocyte extracellular matrix composition, dynamics and role in obesity. Cellular and Molecular Life Sciences, 67(8), 1277–1292. https://doi.org/10.1007/s00018-010-0263-4CrossRefPubMedPubMedCentral

94.

Datta, R., Podolsky, M. J., & Atabai, K. (2018). Fat fibrosis: Friend or foe? Journal of Clinic Investigation Insight, 3(19), e122289. https://doi.org/10.1172/jci.insight.122289CrossRef

95.

Pasarica, M., Gowronska-Kozak, B., Burk, D., Remedios, I., Hymel, D., Gimble, J., et al. (2009). Adipose tissue collagen VI in obesity. Journal of Clinical Endocrinology and Metabolism, 94(12), 5155–5162. https://doi.org/10.1210/jc.2009-0947CrossRefPubMedPubMedCentral

96.

Seo, B. R., Bhardwaj, P., Choi, S., Gonzalez, J., Andresen Eguiluz, R. C., Wang, K., et al. (2015). Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis. Science Translational Medicine, 7(301), 301. https://doi.org/10.1126/scitranslmed.3010467CrossRef

97.

Druso, J. E., & Fischbach, C. (2018). Biophysical properties of extracellular matrix: Linking obesity and cancer. Trends in Cancer, 4(4), 271–273. https://doi.org/10.1016/j.trecan.2018.02.001CrossRefPubMedPubMedCentral

98.

Ruiz-Ojeda, F. J., Méndez-Gutiérrez, A., Aguilera, C. M., & Plaza-Díaz, J. (2019). Extracellular matrix remodeling of adipose tissue in obesity and metabolic diseases. Internationl Journal of Molecular Science, 20(19), 4888. https://doi.org/10.3390/ijms20194888CrossRef

99.

Zhang, Y., Baloglu, F. K., Ziemer, L. E. H., Liu, Z., Lyu, B., Arendt, L. M., et al. (2020). Factors associated with obesity alter matrix remodeling in breast cancer tissues. Journal of Biomedial Optics, 25(1), 1–14. https://doi.org/10.1117/1.Jbo.25.1.014513CrossRef

100.

Rømer, A. M. A., Thorseth, M.-L., & Madsen, D. H. (2021). Immune modulatory properties of collagen in cancer. Frontiers in Immunology, 12, 791453. https://doi.org/10.3389/fimmu.2021.791453CrossRefPubMedPubMedCentral

101.

Nallanthighal, S., Heiserman, J. P., & Cheon, D. J. (2019). The role of the extracellular matrix in cancer stemness. Frontiers in Cell and Developmental Biology, 7, 86. https://doi.org/10.3389/fcell.2019.00086CrossRefPubMedPubMedCentral

102.

McCulloch, L. J., Rawling, T. J., Sjöholm, K., Franck, N., Dankel, S. N., Price, E. J., et al. (2015). COL6A3 is regulated by leptin in human adipose tissue and reduced in obesity. Endocrinology, 156(1), 134–146. https://doi.org/10.1210/en.2014-1042CrossRefPubMed

103.

Khan, T., Muise, E. S., Iyengar, P., Wang, Z. V., Chandalia, M., Abate, N., et al. (2009). Metabolic dysregulation and adipose tissue fibrosis: Role of collagen VI. Molecular and Cellular Biology, 29(6), 1575–1591. https://doi.org/10.1128/mcb.01300-08CrossRefPubMed

104.

Oh, J., Kim, C. S., Kim, M., Jo, W., Sung, Y. H., & Park, J. (2021). Type VI collagen and its cleavage product, endotrophin, cooperatively regulate the adipogenic and lipolytic capacity of adipocytes. Metabolism, 114, 154430. https://doi.org/10.1016/j.metabol.2020.154430CrossRefPubMed

105.

Spencer, M., Yao-Borengasser, A., Unal, R., Rasouli, N., Gurley, C. M., Zhu, B., et al. (2010). Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. American journal of physiology. Endocrinology and metabolism, 299(6), E1016-1027. https://doi.org/10.1152/ajpendo.00329.2010CrossRefPubMedPubMedCentral

106.

Spencer, M., Unal, R., Zhu, B., Rasouli, N., McGehee, R. E., Jr., Peterson, C. A., et al. (2011). Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. Journal of Clinical Endocrinology and Metabolism, 96(12), E1990-1998. https://doi.org/10.1210/jc.2011-1567CrossRefPubMedPubMedCentral

107.

Chen, P., Cescon, M., & Bonaldo, P. (2013). Collagen VI in cancer and its biological mechanisms. Trends in Molecular Medicine, 19(7), 410–417. https://doi.org/10.1016/j.molmed.2013.04.001CrossRefPubMed

108.

Nallanthighal, S., Heiserman, J. P., & Cheon, D.-J. (2019). The role of the extracellular matrix in cancer stemness. Frontiers in Cell and Developmental Biology, 7, 86. https://doi.org/10.3389/fcell.2019.00086CrossRefPubMedPubMedCentral

109.

Ho, C. M., Chang, T. H., Yen, T. L., Hong, K. J., & Huang, S. H. (2021). Collagen type VI regulates the CDK4/6-p-Rb signaling pathway and promotes ovarian cancer invasiveness, stemness, and metastasis. American Journal of Cancer Research, 11(3), 668–690.PubMedPubMedCentral

110.

Byrne, C. E., Decombe, J. B., Bingham, G. C., Remont, J., Miller, L. G., Khalif, L., et al. (2021). Evaluation of extracellular matrix composition to improve breast cancer modeling. Tissue Engineering Part A, 27(7–8), 500–511. https://doi.org/10.1089/ten.TEA.2020.0364CrossRefPubMedPubMedCentral

111.

Insua-Rodríguez, J., & Oskarsson, T. (2016). The extracellular matrix in breast cancer. Advanced Drug Delivery Reviews, 97, 41–55. https://doi.org/10.1016/j.addr.2015.12.017CrossRefPubMed

112.

Pan, Y., Yu, Y., Wang, X., & Zhang, T. (2020). Tumor-associated macrophages in tumor immunity. Frontiers in Immunology, 11, 583084. https://doi.org/10.3389/fimmu.2020.583084CrossRefPubMedPubMedCentral

113.

Williams, L. M., McCann, F. E., Cabrita, M. A., Layton, T., Cribbs, A., Knezevic, B., et al. (2020). Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300. Proceedings of the National Academy of Sciences 117(34):20753-20763 https://doi.org/10.1073/pnas.2004281117

114.

Acerbi, I., Cassereau, L., Dean, I., Shi, Q., Au, A., Park, C., et al. (2015). Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. Integr Biol (Camb), 7(10), 1120–1134. https://doi.org/10.1039/c5ib00040hCrossRef

115.

Reggio, S., Rouault, C., Poitou, C., Bichet, J. C., Prifti, E., Bouillot, J. L., et al. (2016). Increased basement membrane components in adipose tissue during obesity: Links with TGFβ and Metabolic Phenotypes. Journal of Clinical Endocrinology and Metabolism, 101(6), 2578–2587. https://doi.org/10.1210/jc.2015-4304CrossRefPubMed

116.

Nakazeki, F., Nishiga, M., Horie, T., Nishi, H., Nakashima, Y., Baba, O., et al. (2018). Loss of periostin ameliorates adipose tissue inflammation and fibrosis in vivo. Science and Reports, 8(1), 8553. https://doi.org/10.1038/s41598-018-27009-9CrossRef

117.

Walker, C., Mojares, E., & Del Río Hernández, A. (2018). Role of extracellular matrix in development and cancer progression. International Journal of Molecular Science, 19(10), 3028. https://doi.org/10.3390/ijms19103028CrossRef

118.

Belgodere, J. A., King, C. T., Bursavich, J. B., Burow, M. E., Martin, E. C., & Jung, J. P. (2018). Engineering breast cancer microenvironments and 3D bioprinting. Frontiers in Bioengineering and Biotechnology, 6, 66. https://doi.org/10.3389/fbioe.2018.00066CrossRefPubMedPubMedCentral

119.

Catalán, V., Gómez-Ambrosi, J., Rodríguez, A., Ramírez, B., Rotellar, F., Valentí, V., et al. (2012). Increased tenascin C and Toll-like receptor 4 levels in visceral adipose tissue as a link between inflammation and extracellular matrix remodeling in obesity. Journal of Clinical Endocrinology and Metabolism, 97(10), E1880-1889. https://doi.org/10.1210/jc.2012-1670CrossRefPubMedPubMedCentral

120.

Kidd, S., Spaeth, E., Watson, K., Burks, J., Lu, H., Klopp, A., et al. (2012). Origins of the tumor microenvironment: Quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS ONE, 7(2), e30563. https://doi.org/10.1371/journal.pone.0030563CrossRefPubMedPubMedCentral

121.

Miyazaki, Y., Oda, T., Mori, N., & Kida, Y. S. (2020). Adipose-derived mesenchymal stem cells differentiate into pancreatic cancer-associated fibroblasts in vitro. FEBS Open Bio, 10(11), 2268–2281. https://doi.org/10.1002/2211-5463.12976CrossRefPubMedPubMedCentral

122.

Miyazaki, Y., Oda, T., Inagaki, Y., Kushige, H., Saito, Y., Mori, N., et al. (2021). Adipose-derived mesenchymal stem cells differentiate into heterogeneous cancer-associated fibroblasts in a stroma-rich xenograft model. Science and Reports, 11(1), 4690. https://doi.org/10.1038/s41598-021-84058-3CrossRef

123.

Tan, H. X., Xiao, Z. G., Huang, T., Fang, Z. X., Liu, Y., & Huang, Z. C. (2020). CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development. Cancer Biology & Therapy, 21(3), 248–257. https://doi.org/10.1080/15384047.2019.1685156CrossRef

124.

Brock, C. K., Hebert, K. L., Artiles, M., Wright, M. K., Cheng, T., Windsor, G. O., et al. (2021). A role for adipocytes and adipose stem cells in the breast tumor microenvironment and regenerative medicine. Frontiers in Physiology, 12, 751239. https://doi.org/10.3389/fphys.2021.751239CrossRefPubMedPubMedCentral

125.

Bukowska, J., Alarcon Uquillas, A., Wu, X., Frazier, T., Walendzik, K., Vanek, M., et al. (2020). Safety and efficacy of human adipose-derived stromal/stem cell therapy in an immunocompetent murine pressure ulcer model. Stem Cells Development, 29(7), 440–451. https://doi.org/10.1089/scd.2019.0244CrossRefPubMedPubMedCentral

126.

Bernard, J. J., & Wellberg, E. A. (2021). The tumor promotional role of adipocytes in the breast cancer microenvironment and macroenvironment. American Journal of Pathology, 191(8), 1342–1352. https://doi.org/10.1016/j.ajpath.2021.02.006CrossRefPubMedPubMedCentral

127.

Dvorak, H. F. (2015). Tumors: Wounds that do not heal-redux. Cancer Immunology Research, 3(1), 1–11. https://doi.org/10.1158/2326-6066.Cir-14-0209CrossRefPubMedPubMedCentral

128.

Dvorak, H. F. (2019). Tumors: Wounds that do not heal-a historical perspective with a focus on the fundamental roles of increased vascular permeability and clotting. Seminars in Thrombosis and Hemostasis, 45(6), 576–592. https://doi.org/10.1055/s-0039-1687908CrossRefPubMed

129.

Li, C., Jiang, P., Wei, S., Xu, X., & Wang, J. (2020). Regulatory T cells in tumor microenvironment: New mechanisms, potential therapeutic strategies and future prospects. Molecular Cancer, 19(1), 116. https://doi.org/10.1186/s12943-020-01234-1CrossRefPubMedPubMedCentral

130.

Cho, J. A., Park, H., Lim, E. H., & Lee, K. W. (2012). Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells. International Journal of Oncology, 40(1), 130–138. https://doi.org/10.3892/ijo.2011.1193CrossRefPubMed

131.

Jotzu, C., Alt, E., Welte, G., Li, J., Hennessy, B. T., Devarajan, E., et al. (2010). Adipose tissue-derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor-derived factors. Analytical Cellular Pathology (Amsterdam), 33(2), 61–79. https://doi.org/10.3233/acp-clo-2010-0535CrossRef

132.

Zhang, Y., Daquinag, A., Traktuev, D. O., Amaya-Manzanares, F., Simmons, P. J., March, K. L., et al. (2009). White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Research, 69(12), 5259–5266. https://doi.org/10.1158/0008-5472.Can-08-3444CrossRefPubMed

133.

Shimoda, M., Mellody, K. T., & Orimo, A. (2010). Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Seminars in Cell & Developmental Biology, 21(1), 19–25. https://doi.org/10.1016/j.semcdb.2009.10.002CrossRef

134.

Hasegawa, T., Yashiro, M., Nishii, T., Matsuoka, J., Fuyuhiro, Y., Morisaki, T., et al. (2014). Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling. International Journal of Cancer, 134(8), 1785–1795. https://doi.org/10.1002/ijc.28520CrossRefPubMed

135.

Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., et al. (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell, 121(3), 335–348. https://doi.org/10.1016/j.cell.2005.02.034CrossRefPubMed

136.

Mueller, L., Goumas, F. A., Affeldt, M., Sandtner, S., Gehling, U. M., Brilloff, S., et al. (2007). Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment. American Journal of Pathology, 171(5), 1608–1618. https://doi.org/10.2353/ajpath.2007.060661CrossRefPubMedPubMedCentral

137.

Strong, A. L., Burow, M. E., Gimble, J. M., & Bunnell, B. A. (2015). Concise review: The obesity cancer paradigm: Exploration of the interactions and crosstalk with adipose stem cells. Stem Cells, 33(2), 318–326. https://doi.org/10.1002/stem.1857CrossRefPubMed

138.

Studeny, M., Marini, F. C., Champlin, R. E., Zompetta, C., Fidler, I. J., & Andreeff, M. (2002). Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Research, 62(13), 3603–3608.PubMed

139.

Studeny, M., Marini, F. C., Dembinski, J. L., Zompetta, C., Cabreira-Hansen, M., Bekele, B. N., et al. (2004). Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. Journal of the National Cancer Institute, 96(21), 1593–1603. https://doi.org/10.1093/jnci/djh299CrossRefPubMed

140.

Nakamizo, A., Marini, F., Amano, T., Khan, A., Studeny, M., Gumin, J., et al. (2005). Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Research, 65(8), 3307–3318. https://doi.org/10.1158/0008-5472.Can-04-1874CrossRefPubMed

141.

Menon, L. G., Kelly, K., Yang, H. W., Kim, S. K., Black, P. M., & Carroll, R. S. (2009). Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells, 27(9), 2320–2330. https://doi.org/10.1002/stem.136CrossRefPubMed

142.

Zimmerlin, L., Donnenberg, A. D., Rubin, J. P., Basse, P., Landreneau, R. J., & Donnenberg, V. S. (2011). Regenerative therapy and cancer: In vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Engineering Part A, 17(1–2), 93–106. https://doi.org/10.1089/ten.TEA.2010.0248CrossRefPubMed

143.

Belmar-Lopez, C., Mendoza, G., Oberg, D., Burnet, J., Simon, C., Cervello, I., et al. (2013). Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivo effects on migration capacity and tumor growth. Bmc Medicine, 11, 139. https://doi.org/10.1186/1741-7015-11-139CrossRefPubMedPubMedCentral

144.

Kalimuthu, S., Zhu, L., Oh, J. M., Gangadaran, P., Lee, H. W., Baek, S. H., et al. (2018). Migration of mesenchymal stem cells to tumor xenograft models and in vitro drug delivery by doxorubicin. International Journal of Medical Sciences, 15(10), 1051–1061. https://doi.org/10.7150/ijms.25760CrossRefPubMedPubMedCentral

145.

Cho, J. A., Park, H., Lim, E. H., Kim, K. H., Choi, J. S., Lee, J. H., et al. (2011). Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts. Gynecologic Oncology, 123(2), 379–386. https://doi.org/10.1016/j.ygyno.2011.08.005CrossRefPubMed

146.

Devarajan, E., Song, Y. H., Krishnappa, S., & Alt, E. (2012). Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells. International Journal of Cancer, 131(5), 1023–1031. https://doi.org/10.1002/ijc.26493CrossRefPubMed

147.

Tuxhorn, J. A., Ayala, G. E., Smith, M. J., Smith, V. C., Dang, T. D., & Rowley, D. R. (2002). Reactive stroma in human prostate cancer: Induction of myofibroblast phenotype and extracellular matrix remodeling. Clinical Cancer Research, 8(9), 2912–2923.PubMed

148.

De Boeck, A., Hendrix, A., Maynard, D., Van Bockstal, M., Daniëls, A., Pauwels, P., et al. (2013). Differential secretome analysis of cancer-associated fibroblasts and bone marrow-derived precursors to identify microenvironmental regulators of colon cancer progression. Proteomics, 13(2), 379–388. https://doi.org/10.1002/pmic.201200179CrossRefPubMed

149.

Arendt, L. M., McCready, J., Keller, P. J., Baker, D. D., Naber, S. P., Seewaldt, V., et al. (2013). Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis. Cancer Research, 73(19), 6080–6093. https://doi.org/10.1158/0008-5472.Can-13-0926CrossRefPubMed

150.

Castro-Oropeza, R., Vazquez-Santillan, K., Díaz-Gastelum, C., Melendez-Zajgla, J., Zampedri, C., Ferat-Osorio, E., et al. (2020). Adipose-derived mesenchymal stem cells promote the malignant phenotype of cervical cancer. Science and Reports, 10(1), 14205. https://doi.org/10.1038/s41598-020-69907-xCrossRef

151.

Hutchings, G., Janowicz, K., Moncrieff, L., Dompe, C., Strauss, E., Kocherova, I., et al. (2020). The proliferation and differentiation of adipose-derived stem cells in neovascularization and angiogenesis. International Journal of Molecular Science, 21(11), 3790. https://doi.org/10.3390/ijms21113790CrossRef

152.

Preisner, F., Leimer, U., Sandmann, S., Zoernig, I., Germann, G., & Koellensperger, E. (2018). Impact of human adipose tissue-derived stem cells on malignant melanoma cells in an in vitro co-culture model. Stem Cell Reviews and Reports, 14(1), 125–140. https://doi.org/10.1007/s12015-017-9772-yCrossRefPubMed

153.

Salha, S., Gehmert, S., Brébant, V., Anker, A., Loibl, M., Prantl, L., et al. (2018). PDGF regulated migration of mesenchymal stem cells towards malignancy acts via the PI3K signaling pathway. Clinical Hemorheology and Microcirculation, 70(4), 543–551. https://doi.org/10.3233/ch-189319CrossRefPubMed

154.

Zhang, W., Torres-Rojas, C., Yue, J., & Zhu, B. M. (2021). Adipose-derived stem cells in ovarian cancer progression, metastasis, and chemoresistance. Experimental Biology and Medicine (Maywood), 246(16), 1810–1815. https://doi.org/10.1177/15353702211023846CrossRef

155.

Chandler, E. M., Saunders, M. P., Yoon, C. J., Gourdon, D., & Fischbach, C. (2011). Adipose progenitor cells increase fibronectin matrix strain and unfolding in breast tumors. Physical Biology, 8(1), 015008. https://doi.org/10.1088/1478-3975/8/1/015008CrossRefPubMed

156.

Samarajeewa, N. U., Yang, F., Docanto, M. M., Sakurai, M., McNamara, K. M., Sasano, H., et al. (2013). HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma. Breast Cancer Research, 15(2), R30. https://doi.org/10.1186/bcr3410CrossRefPubMedPubMedCentral

157.

Ribeiro, R., Monteiro, C., Silvestre, R., Castela, A., Coutinho, H., Fraga, A., et al. (2012). Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma. Experimental Biology and Medicine (Maywood), 237(10), 1155–1162. https://doi.org/10.1258/ebm.2012.012131CrossRef

158.

Walter, M., Liang, S., Ghosh, S., Hornsby, P. J., & Li, R. (2009). Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene, 28(30), 2745–2755. https://doi.org/10.1038/onc.2009.130CrossRefPubMedPubMedCentral

159.

Lin, G., Yang, R., Banie, L., Wang, G., Ning, H., Li, L. C., et al. (2010). Effects of transplantation of adipose tissue-derived stem cells on prostate tumor. Prostate, 70(10), 1066–1073. https://doi.org/10.1002/pros.21140CrossRefPubMedPubMedCentral

160.

Muehlberg, F. L., Song, Y. H., Krohn, A., Pinilla, S. P., Droll, L. H., Leng, X., et al. (2009). Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis, 30(4), 589–597. https://doi.org/10.1093/carcin/bgp036CrossRefPubMed

161.

Rowan, B. G., Gimble, J. M., Sheng, M., Anbalagan, M., Jones, R. K., Frazier, T. P., et al. (2014). Human adipose tissue-derived stromal/stem cells promote migration and early metastasis of triple negative breast cancer xenografts. PLoS ONE, 9(2), e89595. https://doi.org/10.1371/journal.pone.0089595CrossRefPubMedPubMedCentral

162.

Li, W., Xu, H., & Qian, C. (2017). c-Kit-positive adipose tissue-derived mesenchymal stem cells promote the growth and angiogenesis of breast cancer. BioMed Research International, 2017, 7407168. https://doi.org/10.1155/2017/7407168CrossRefPubMedPubMedCentral

163.

Nakopoulou, L., Tsirmpa, I., Alexandrou, P., Louvrou, A., Ampela, C., Markaki, S., et al. (2003). MMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival. Breast Cancer Research and Treatment, 77(2), 145–155. https://doi.org/10.1023/a:1021371028777CrossRefPubMed

164.

Quintero-Fabián, S., Arreola, R., Becerril-Villanueva, E., Torres-Romero, J. C., Arana-Argáez, V., Lara-Riegos, J., et al. (2019). Role of matrix metalloproteinases in angiogenesis and cancer. Frontiers in Oncology, 9, 1370. https://doi.org/10.3389/fonc.2019.01370CrossRefPubMedPubMedCentral

165.

Curran, S., & Murray, G. I. (2000). Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. European Journal of Cancer, 36(13), 1621–1630. https://doi.org/10.1016/s0959-8049(00)00156-8CrossRefPubMed

166.

Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002). Matrix metalloproteinase inhibitors and cancer: Trials and tribulations. Science, 295(5564), 2387–2392. https://doi.org/10.1126/science.1067100CrossRefPubMed

167.

Egeblad, M., & Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nature Reviews Cancer, 2(3), 161–174. https://doi.org/10.1038/nrc745CrossRefPubMed

168.

Baker, A. H., Zaltsman, A. B., George, S. J., & Newby, A. C. (1998). Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. Journal of Clinical Investigation, 101(6), 1478–1487. https://doi.org/10.1172/jci1584CrossRefPubMedPubMedCentral

169.

Park, H. Y., Kwon, H. M., Lim, H. J., Hong, B. K., Lee, J. Y., Park, B. E., et al. (2001). Potential role of leptin in angiogenesis: Leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Experimental & Molecular Medicine, 33(2), 95–102. https://doi.org/10.1038/emm.2001.17CrossRef

170.

Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijima, E., & Iwata, K. (1992). Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. Febs Letters, 298(1), 29–32. https://doi.org/10.1016/0014-5793(92)80015-9CrossRefPubMed

171.

Pinilla, S., Alt, E., Abdul Khalek, F. J., Jotzu, C., Muehlberg, F., Beckmann, C., et al. (2009). Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Letters, 284(1), 80–85. https://doi.org/10.1016/j.canlet.2009.04.013CrossRefPubMed

172.

Welte, G., Alt, E., Devarajan, E., Krishnappa, S., Jotzu, C., & Song, Y. H. (2012). Interleukin-8 derived from local tissue-resident stromal cells promotes tumor cell invasion. Molecular Carcinogenesis, 51(11), 861–868. https://doi.org/10.1002/mc.20854CrossRefPubMed

173.

Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021). Cancer statistics, 2021. Ca: A Cancer Journal for Clinicians, 71(1), 7–33. https://doi.org/10.3322/caac.21654CrossRef

174.

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660CrossRef

175.

Hendrick, R. E., Helvie, M. A., & Monticciolo, D. L. (2021). Breast cancer mortality rates have stopped declining in U.S. women younger than 40 years. Radiology, 299(1), 143–149. https://doi.org/10.1148/radiol.2021203476CrossRefPubMed

176.

Waks, A. G., & Winer, E. P. (2019). Breast cancer treatment: A review. Jama, 321(3), 288–300. https://doi.org/10.1001/jama.2018.19323CrossRefPubMed

177.

Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., et al. (2011). Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. The Journal of Clinical Investigation, 121(7), 2750–2767. https://doi.org/10.1172/jci45014CrossRefPubMedPubMedCentral

178.

Lehmann, B. D., & Pietenpol, J. A. (2014). Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes. The Journal of Pathology, 232(2), 142–150. https://doi.org/10.1002/path.4280CrossRefPubMed

179.

Bianchini, G., Balko, J. M., Mayer, I. A., Sanders, M. E., & Gianni, L. (2016). Triple-negative breast cancer: Challenges and opportunities of a heterogeneous disease. Nature Reviews. Clinical Oncology, 13(11), 674–690. https://doi.org/10.1038/nrclinonc.2016.66CrossRefPubMedPubMedCentral

180.

Killelea, B. K., Yang, V. Q., Mougalian, S., Horowitz, N. R., Pusztai, L., Chagpar, A. B., et al. (2015). Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: Results from the National Cancer Database. Journal of the American College of Surgeons, 220(6), 1063–1069. https://doi.org/10.1016/j.jamcollsurg.2015.02.011CrossRefPubMed

181.

Paradiso, A., & Singer, C. F. (2017). Therapeutic strategies in triple-negative breast cancer. Breast Care (Basel), 12(1), 6–7. https://doi.org/10.1159/000460238CrossRef

182.

Barnard, M. E., Boeke, C. E., & Tamimi, R. M. (2015). Established breast cancer risk factors and risk of intrinsic tumor subtypes. Biochimica et Biophysica Acta, 1856(1), 73–85. https://doi.org/10.1016/j.bbcan.2015.06.002CrossRefPubMed

183.

Arthur, R., Wassertheil-Smoller, S., Manson, J. E., Luo, J., Snetselaar, L., Hastert, T., et al. (2018). The combined association of modifiable risk factors with breast cancer risk in the Women’s Health Initiative. Cancer Prevention Research (Philadelphia), 11(6), 317–326. https://doi.org/10.1158/1940-6207.Capr-17-0347CrossRef

184.

Boyle, P. (2012). Triple-negative breast cancer: Epidemiological considerations and recommendations. Annals of Oncology, 23(Suppl 6), vi7–vi12. https://doi.org/10.1093/annonc/mds187CrossRefPubMed

185.

Plasilova, M. L., Hayse, B., Killelea, B. K., Horowitz, N. R., Chagpar, A. B., & Lannin, D. R. (2016). Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database. Medicine (Baltimore), 95(35), e4614. https://doi.org/10.1097/md.0000000000004614CrossRef

186.

Lambertini, M., Santoro, L., Del Mastro, L., Nguyen, B., Livraghi, L., Ugolini, D., et al. (2016). Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies. Cancer Treatment Reviews, 49, 65–76. https://doi.org/10.1016/j.ctrv.2016.07.006CrossRefPubMed

187.

Lee, K., Kruper, L., Dieli-Conwright, C. M., & Mortimer, J. E. (2019). The impact of obesity on breast cancer diagnosis and treatment. Current Oncology Reports, 21(5), 41. https://doi.org/10.1007/s11912-019-0787-1CrossRefPubMedPubMedCentral

188.

Ramos-Lobo, A. M., & Donato, J., Jr. (2017). The role of leptin in health and disease. Temperature (Austin), 4(3), 258–291. https://doi.org/10.1080/23328940.2017.1327003CrossRef

189.

Francisco, V., Pino, J., Campos-Cabaleiro, V., Ruiz-Fernández, C., Mera, A., Gonzalez-Gay, M. A., et al. (2018). Obesity, fat mass and immune system: Role for leptin. Frontiers in Physiology, 9, 640. https://doi.org/10.3389/fphys.2018.00640CrossRefPubMedPubMedCentral

190.

Lin, T. C., Huang, K. W., Liu, C. W., Chang, Y. C., Lin, W. M., Yang, T. Y., et al. (2018). Leptin signaling axis specifically associates with clinical prognosis and is multifunctional in regulating cancer progression. Oncotarget, 9(24), 17210–17219. https://doi.org/10.18632/oncotarget.24966CrossRefPubMedPubMedCentral

191.

Cleary, M. P., Grossmann, M. E., & Ray, A. (2010). Effect of obesity on breast cancer development. Veterinary Pathology, 47(2), 202–213. https://doi.org/10.1177/0300985809357753CrossRefPubMed

192.

Grossmann, M. E., Ray, A., Nkhata, K. J., Malakhov, D. A., Rogozina, O. P., Dogan, S., et al. (2010). Obesity and breast cancer: Status of leptin and adiponectin in pathological processes. Cancer and Metastasis Reviews, 29(4), 641–653. https://doi.org/10.1007/s10555-010-9252-1CrossRefPubMed

193.

Argolo, D. F., Hudis, C. A., & Iyengar, N. M. (2018). The impact of obesity on breast cancer. Current Oncology Reports, 20(6), 47. https://doi.org/10.1007/s11912-018-0688-8CrossRefPubMed

194.

Brown, K. A. (2021). Metabolic pathways in obesity-related breast cancer. Nature Reviews Endocrinology, 17(6), 350–363. https://doi.org/10.1038/s41574-021-00487-0CrossRefPubMed

195.

Kato, S., Abarzua-Catalan, L., Trigo, C., Delpiano, A., Sanhueza, C., García, K., et al. (2015). Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: An explanation for poor outcomes in obese women. Oncotarget, 6(25), 21100–21119. https://doi.org/10.18632/oncotarget.4228CrossRefPubMedPubMedCentral

196.

Strong, A. L., Ohlstein, J. F., Biagas, B. A., Rhodes, L. V., Pei, D. T., Tucker, H. A., et al. (2015). Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers. Breast Cancer Research, 17(1), 112. https://doi.org/10.1186/s13058-015-0622-zCrossRefPubMedPubMedCentral

197.

García-Robles, M. J., Segura-Ortega, J. E., & Fafutis-Morris, M. (2013). The biology of leptin and its implications in breast cancer: A general view. Journal of Interferon and Cytokine Research, 33(12), 717–727. https://doi.org/10.1089/jir.2012.0168CrossRefPubMed

198.

Pan, H., Deng, L. L., Cui, J. Q., Shi, L., Yang, Y. C., Luo, J. H., et al. (2018). Association between serum leptin levels and breast cancer risk: An updated systematic review and meta-analysis. Medicine (Baltimore), 97(27), e11345. https://doi.org/10.1097/md.0000000000011345CrossRef

199.

Ray, A., & Cleary, M. P. (2010). Leptin as a potential therapeutic target for breast cancer prevention and treatment. Expert Opinion on Therapeutic Targets, 14(4), 443–451. https://doi.org/10.1517/14728221003716466CrossRefPubMed

200.

Sánchez-Jiménez, F., Pérez-Pérez, A., de la Cruz-Merino, L., & Sánchez-Margalet, V. (2019). Obesity and breast cancer: Role of leptin. Frontiers in Oncology, 9, 596. https://doi.org/10.3389/fonc.2019.00596CrossRefPubMedPubMedCentral

201.

Dieudonne, M. N., Machinal-Quelin, F., Serazin-Leroy, V., Leneveu, M. C., Pecquery, R., & Giudicelli, Y. (2002). Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochemical and Biophysical Research Communications, 293(1), 622–628. https://doi.org/10.1016/s0006-291x(02)00205-xCrossRefPubMed

202.

Laud, K., Gourdou, I., Pessemesse, L., Peyrat, J. P., & Djiane, J. (2002). Identification of leptin receptors in human breast cancer: Functional activity in the T47-D breast cancer cell line. Molecular and Cellular Endocrinology, 188(1–2), 219–226. https://doi.org/10.1016/s0303-7207(01)00678-5CrossRefPubMed

203.

Somasundar, P., Yu, A. K., Vona-Davis, L., & McFadden, D. W. (2003). Differential effects of leptin on cancer in vitro. Journal of Surgical Research, 113(1), 50–55. https://doi.org/10.1016/s0022-4804(03)00166-5CrossRefPubMed

204.

Yin, N., Wang, D., Zhang, H., Yi, X., Sun, X., Shi, B., et al. (2004). Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Research, 64(16), 5870–5875. https://doi.org/10.1158/0008-5472.Can-04-0655CrossRefPubMed

205.

Jardé, T., Caldefie-Chézet, F., Goncalves-Mendes, N., Mishellany, F., Buechler, C., Penault-Llorca, F., et al. (2009). Involvement of adiponectin and leptin in breast cancer: Clinical and in vitro studies. Endocrine-Related Cancer, 16(4), 1197–1210. https://doi.org/10.1677/erc-09-0043CrossRefPubMed

206.

Garofalo, C., Koda, M., Cascio, S., Sulkowska, M., Kanczuga-Koda, L., Golaszewska, J., et al. (2006). Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: Possible role of obesity-related stimuli. Clinical Cancer Research, 12(5), 1447–1453. https://doi.org/10.1158/1078-0432.Ccr-05-1913CrossRefPubMed

207.

Gelsomino, L., Giordano, C., Camera, G., Sisci, D., Marsico, S., Campana, A., et al. (2020). Leptin signaling contributes to aromatase inhibitor resistant breast cancer cell growth and activation of macrophages. Biomolecules, 10(4), 543. https://doi.org/10.3390/biom10040543CrossRefPubMedCentral

208.

Catalano, S., Marsico, S., Giordano, C., Mauro, L., Rizza, P., Panno, M. L., et al. (2003). Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. Journal of Biological Chemistry, 278(31), 28668–28676. https://doi.org/10.1074/jbc.M301695200CrossRefPubMed

209.

Frankenberry, K. A., Skinner, H., Somasundar, P., McFadden, D. W., & Vona-Davis, L. C. (2006). Leptin receptor expression and cell signaling in breast cancer. International Journal of Oncology, 28(4), 985–993.PubMed

210.

Gao, J., Tian, J., Lv, Y., Shi, F., Kong, F., Shi, H., et al. (2009). Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells. Cancer Science, 100(3), 389–395. https://doi.org/10.1111/j.1349-7006.2008.01053.xCrossRefPubMed

211.

Jotzu, C., Alt, E., Welte, G., Li, J., Hennessy, B. T., Devarajan, E., et al. (2011). Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors. Cellular Oncology (Dordrecht), 34(1), 55–67. https://doi.org/10.1007/s13402-011-0012-1CrossRef

212.

Kucerova, L., Altanerova, V., Matuskova, M., Tyciakova, S., & Altaner, C. (2007). Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Research, 67(13), 6304–6313. https://doi.org/10.1158/0008-5472.Can-06-4024CrossRefPubMed

213.

Bajou, K., Noël, A., Gerard, R. D., Masson, V., Brunner, N., Holst-Hansen, C., et al. (1998). Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nature Medicine, 4(8), 923–928. https://doi.org/10.1038/nm0898-923CrossRefPubMed

214.

Hildenbrand, R., & Schaaf, A. (2009). The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. International Journal of Oncology, 34(1), 15–23.PubMed

215.

Mendes, O., Kim, H. T., & Stoica, G. (2005). Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. Clinical & Experimental Metastasis, 22(3), 237–246. https://doi.org/10.1007/s10585-005-8115-6CrossRef

216.

Mendes, O., Kim, H. T., Lungu, G., & Stoica, G. (2007). MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2. Clinical & Experimental Metastasis, 24(5), 341–351. https://doi.org/10.1007/s10585-007-9071-0CrossRef

217.

Pellikainen, J. M., Ropponen, K. M., Kataja, V. V., Kellokoski, J. K., Eskelinen, M. J., & Kosma, V. M. (2004). Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Clinical Cancer Research, 10(22), 7621–7628. https://doi.org/10.1158/1078-0432.Ccr-04-1061CrossRefPubMed

218.

Ren, F., Tang, R., Zhang, X., Madushi, W. M., Luo, D., Dang, Y., et al. (2015). Overexpression of MMP family members functions as prognostic biomarker for breast cancer patients: A systematic review and meta-analysis. PLoS ONE, 10(8), e0135544. https://doi.org/10.1371/journal.pone.0135544CrossRefPubMedPubMedCentral

219.

Kars, M. D., Işeri, O. D., & Gündüz, U. (2011). A microarray based expression profiling of paclitaxel and vincristine resistant MCF-7 cells. European Journal of Pharmacology, 657(1–3), 4–9. https://doi.org/10.1016/j.ejphar.2011.02.001CrossRefPubMed

220.

Zhao, Y., Zhang, X., Zhao, H., Wang, J., & Zhang, Q. (2018). CXCL5 secreted from adipose tissue-derived stem cells promotes cancer cell proliferation. Oncology Letters, 15(2), 1403–1410. https://doi.org/10.3892/ol.2017.7522CrossRefPubMed

221.

Sakurai, M., Miki, Y., Takagi, K., Suzuki, T., Ishida, T., Ohuchi, N., et al. (2017). Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment. Breast Cancer Research, 19(1), 70. https://doi.org/10.1186/s13058-017-0863-0CrossRefPubMedPubMedCentral

222.

Sabol, R. A., Beighley, A., Giacomelli, P., Wise, R. M., Harrison, M. A. A., O’Donnnell, B. A., et al. (2019). Obesity-altered adipose stem cells promote ER⁺ breast cancer metastasis through estrogen independent pathways. International Journal of Molecular Science, 20(6), 1419. https://doi.org/10.3390/ijms20061419CrossRef

223.

Alluri, P., & Newman, L. A. (2014). Basal-like and triple-negative breast cancers: Searching for positives among many negatives. Surgical Oncology Clinics of North America, 23(3), 567–577. https://doi.org/10.1016/j.soc.2014.03.003CrossRefPubMedPubMedCentral

224.

Wu, Q., Siddharth, S., & Sharma, D. (2021). Triple negative breast cancer: A mountain yet to be scaled despite the triumphs. Cancers (Basel), 13(15), 3697. https://doi.org/10.3390/cancers13153697CrossRefPubMedCentral

225.

Dent, R., Trudeau, M., Pritchard, K. I., Hanna, W. M., Kahn, H. K., Sawka, C. A., et al. (2007). Triple-negative breast cancer: Clinical features and patterns of recurrence. Clinical Cancer Research, 13(15 Pt 1), 4429–4434. https://doi.org/10.1158/1078-0432.Ccr-06-3045CrossRefPubMed

226.

Sabol, R. A., Bowles, A. C., Côté, A., Wise, R., O’Donnell, B., Matossian, M. D., et al. (2019). Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models. Breast Cancer Research, 21(1), 67. https://doi.org/10.1186/s13058-019-1153-9CrossRefPubMedPubMedCentral

227.

Wei, H. J., Zeng, R., Lu, J. H., Lai, W. F., Chen, W. H., Liu, H. Y., et al. (2015). Adipose-derived stem cells promote tumor initiation and accelerate tumor growth by interleukin-6 production. Oncotarget, 6(10), 7713–7726. https://doi.org/10.18632/oncotarget.3481CrossRefPubMedPubMedCentral

228.

Eterno, V., Zambelli, A., Pavesi, L., Villani, L., Zanini, V., Petrolo, G., et al. (2014). Adipose-derived Mesenchymal Stem Cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling. Oncotarget, 5(3), 613–633. https://doi.org/10.18632/oncotarget.1359CrossRefPubMed

229.

Divella, R., De Luca, R., Abbate, I., Naglieri, E., & Daniele, A. (2016). Obesity and cancer: The role of adipose tissue and adipo-cytokines-induced chronic inflammation. Journal of Cancer, 7(15), 2346–2359. https://doi.org/10.7150/jca.16884CrossRefPubMedPubMedCentral

230.

Di Franco, S., Bianca, P., Sardina, D. S., Turdo, A., Gaggianesi, M., Veschi, V., et al. (2021). Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery. Nature Communications, 12(1), 5006. https://doi.org/10.1038/s41467-021-25333-9CrossRefPubMedPubMedCentral

231.

Chen, D., Liu, S., Ma, H., Liang, X., Ma, H., Yan, X., et al. (2015). Paracrine factors from adipose-mesenchymal stem cells enhance metastatic capacity through Wnt signaling pathway in a colon cancer cell co-culture model. Cancer Cell International, 15, 42. https://doi.org/10.1186/s12935-015-0198-9CrossRefPubMedPubMedCentral

232.

Li, Y., Xu, X., Wang, L., Liu, G., Li, Y., Wu, X., et al. (2015). Senescent mesenchymal stem cells promote colorectal cancer cells growth via galectin-3 expression. Cell & Bioscience, 5, 21. https://doi.org/10.1186/s13578-015-0012-3CrossRef

233.

Toren, P., & Venkateswaran, V. (2014). Periprostatic adipose tissue and prostate cancer progression: New insights into the tumor microenvironment. Clinical Genitourinary Cancer, 12(1), 21–26. https://doi.org/10.1016/j.clgc.2013.07.013CrossRefPubMed

234.

Tang, K. D., Liu, J., Jovanovic, L., An, J., Hill, M. M., Vela, I., et al. (2016). Adipocytes promote prostate cancer stem cell self-renewal through amplification of the cholecystokinin autocrine loop. Oncotarget, 7(4), 4939–4948. https://doi.org/10.18632/oncotarget.6643CrossRefPubMed

235.

Cozzo, A. J., Fuller, A. M., & Makowski, L. (2017). Contribution of adipose tissue to development of cancer. Comprehensive Physiology, 8(1), 237–282. https://doi.org/10.1002/cphy.c170008CrossRefPubMedPubMedCentral

236.

Allott, E. H., Masko, E. M., & Freedland, S. J. (2013). Obesity and prostate cancer: Weighing the evidence. European Urology, 63(5), 800–809. https://doi.org/10.1016/j.eururo.2012.11.013CrossRefPubMed

237.

Saha, A., Ahn, S., Blando, J., Su, F., Kolonin, M. G., & DiGiovanni, J. (2017). Proinflammatory CXCL12-CXCR4/CXCR7 signaling axis drives Myc-induced prostate cancer in obese mice. Cancer Research, 77(18), 5158–5168. https://doi.org/10.1158/0008-5472.Can-17-0284CrossRefPubMedPubMedCentral

238.

Su, F., Daquinag, A. C., Ahn, S., Saha, A., Dai, Y., Zhao, Z., et al. (2021). Progression of prostate carcinoma is promoted by adipose stromal cell-secreted CXCL12 signaling in prostate epithelium. Npj Precis Oncol, 5(1), 26. https://doi.org/10.1038/s41698-021-00160-9CrossRefPubMedPubMedCentral

239.

Zhang, T., Tseng, C., Zhang, Y., Sirin, O., Corn, P. G., Li-Ning-Tapia, E. M., et al. (2016). CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment. Nature Communications, 7, 11674. https://doi.org/10.1038/ncomms11674CrossRefPubMedPubMedCentral

240.

Abd Elmageed, Z. Y., Yang, Y., Thomas, R., Ranjan, M., Mondal, D., Moroz, K., et al. (2014). Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes. Stem Cells, 32(4), 983–997. https://doi.org/10.1002/stem.1619CrossRefPubMed

241.

Fort, R. S., Mathó, C., Oliveira-Rizzo, C., Garat, B., Sotelo-Silveira, J. R., & Duhagon, M. A. (2018). An integrated view of the role of miR-130b/301b miRNA cluster in prostate cancer. Experimental Hematology & Oncology, 7, 10. https://doi.org/10.1186/s40164-018-0102-0CrossRef

242.

Naora, H., & Montell, D. J. (2005). Ovarian cancer metastasis: Integrating insights from disparate model organisms. Nature Reviews Cancer, 5(5), 355–366. https://doi.org/10.1038/nrc1611CrossRefPubMed

243.

Zhang, Y., Nowicka, A., Solley, T. N., Wei, C., Parikh, A., Court, L., et al. (2015). Stromal cells derived from visceral and obese adipose tissue promote growth of ovarian cancers. PLoS ONE, 10(8), e0136361. https://doi.org/10.1371/journal.pone.0136361CrossRefPubMedPubMedCentral

244.

Nowicka, A., Marini, F. C., Solley, T. N., Elizondo, P. B., Zhang, Y., Sharp, H. J., et al. (2013). Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance. PLoS ONE, 8(12), e81859. https://doi.org/10.1371/journal.pone.0081859CrossRefPubMedPubMedCentral

245.

Kim, B., Kim, H. S., Kim, S., Haegeman, G., Tsang, B. K., Dhanasekaran, D. N., et al. (2017). Adipose stromal cells from visceral and subcutaneous fat facilitate migration of ovarian cancer cells via IL-6/JAK2/STAT3 pathway. Cancer Research and Treatment, 49(2), 338–349. https://doi.org/10.4143/crt.2016.175CrossRefPubMed

246.

Chu, Y., You, M., Zhang, J., Gao, G., Han, R., Luo, W., et al. (2019). Adipose-derived mesenchymal stem cells enhance ovarian cancer growth and metastasis by increasing thymosin beta 4X-linked expression. Stem Cells Int, 2019, 9037197. https://doi.org/10.1155/2019/9037197CrossRefPubMedPubMedCentral

247.

Tang, H., Chu, Y., Huang, Z., Cai, J., & Wang, Z. (2020). The metastatic phenotype shift toward myofibroblast of adipose-derived mesenchymal stem cells promotes ovarian cancer progression. Carcinogenesis, 41(2), 182–193. https://doi.org/10.1093/carcin/bgz083CrossRefPubMed

248.

Thériault, B. L., Shepherd, T. G., Mujoomdar, M. L., & Nachtigal, M. W. (2007). BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis, 28(6), 1153–1162. https://doi.org/10.1093/carcin/bgm015CrossRefPubMed

249.

Fukuda, T., Fukuda, R., Tanabe, R., Koinuma, D., Koyama, H., Hashizume, Y., et al. (2020). BMP signaling is a therapeutic target in ovarian cancer. Cell Death Discovery, 6(1), 139. https://doi.org/10.1038/s41420-020-00377-wCrossRefPubMedPubMedCentral

250.

Bullwinkle, E. M., Parker, M. D., Bonan, N. F., Falkenberg, L. G., Davison, S. P., & DeCicco-Skinner, K. L. (2016). Adipocytes contribute to the growth and progression of multiple myeloma: Unraveling obesity related differences in adipocyte signaling. Cancer Letters, 380(1), 114–121. https://doi.org/10.1016/j.canlet.2016.06.010CrossRefPubMed

251.

Yu, W., Cao, D. D., Li, Q. B., Mei, H. L., Hu, Y., & Guo, T. (2016). Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy. Oncotarget, 7(52), 86075–86086. https://doi.org/10.18632/oncotarget.13342CrossRefPubMedPubMedCentral

252.

Wang, Y., Chu, Y., Yue, B., Ma, X., Zhang, G., Xiang, H., et al. (2017). Adipose-derived mesenchymal stem cells promote osteosarcoma proliferation and metastasis by activating the STAT3 pathway. Oncotarget, 8(14), 23803–23816. https://doi.org/10.18632/oncotarget.15866CrossRefPubMedPubMedCentral

253.

Wang, Y., Chu, Y., Li, K., Zhang, G., Guo, Z., Wu, X., et al. (2020). Exosomes secreted by adipose-derived mesenchymal stem cells foster metastasis and osteosarcoma proliferation by increasing COLGALT2 expression. Frontiers in Cell Developmental Biology, 8, 353. https://doi.org/10.3389/fcell.2020.00353CrossRefPubMedPubMedCentral

254.

Tian, T., Li, X., Hua, Z., Ma, J., Wu, X., Liu, Z., et al. (2017). S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transition. Oncotarget, 8(15), 24964–24977. https://doi.org/10.18632/oncotarget.15329CrossRefPubMedPubMedCentral

255.

Zhai, Y., Wu, W., Xi, X., & Yu, R. (2020). Adipose-derived stem cells promote proliferation and invasion in cervical cancer by targeting the HGF/c-MET pathway. Cancer Management and Research, 12, 11823–11832. https://doi.org/10.2147/CMAR.S277130CrossRefPubMedPubMedCentral

256.

Maj, M., Kokocha, A., Bajek, A., & Drewa, T. (2018). The interplay between adipose-derived stem cells and bladder cancer cells. Science and Reports, 8(1), 15118. https://doi.org/10.1038/s41598-018-33397-9CrossRef

257.

Maj, M., Kokocha, A., Bajek, A., & Drewa, T. (2019). The effects of adipose-derived stem cells on CD133-expressing bladder cancer cells. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.28436CrossRefPubMed

258.

Nomoto-Kojima, N., Aoki, S., Uchihashi, K., Matsunobu, A., Koike, E., Ootani, A., et al. (2011). Interaction between adipose tissue stromal cells and gastric cancer cells in vitro. Cell and Tissue Research, 344(2), 287–298. https://doi.org/10.1007/s00441-011-1144-3CrossRefPubMed

259.

Zhao, B. C., Zhao, B., Han, J. G., Ma, H. C., & Wang, Z. J. (2010). Adipose-derived stem cells promote gastric cancer cell growth, migration and invasion through SDF-1/CXCR4 axis. Hepato-Gastroenterology, 57(104), 1382–1389.PubMed

260.

Huang, R., Li, W., Zhao, Y., Yang, F., & Xu, M. (2020). Clinical efficacy and safety of stem cell therapy for knee osteoarthritis: A meta-analysis. Medicine (Baltimore), 99(11), e19434. https://doi.org/10.1097/MD.0000000000019434CrossRef

261.

Hui, W., Litherland, G. J., Elias, M. S., Kitson, G. I., Cawston, T. E., Rowan, A. D., et al. (2012). Leptin produced by joint white adipose tissue induces cartilage degradation via upregulation and activation of matrix metalloproteinases. Annals of the Rheumatic Diseases, 71(3), 455–462. https://doi.org/10.1136/annrheumdis-2011-200372CrossRefPubMed

262.

Danan, D., Lehman, C. E., Mendez, R. E., Langford, B., Koors, P. D., Dougherty, M. I., et al. (2018). Effect of adipose-derived stem cells on head and neck squamous cell carcinoma. Otolaryngology - Head and Neck Surgery, 158(5), 882–888. https://doi.org/10.1177/0194599817750361CrossRefPubMed

263.

Scioli, M. G., Storti, G., D’Amico, F., Gentile, P., Kim, B. S., Cervelli, V., et al. (2019). Adipose-derived stem cells in cancer progression: New perspectives and opportunities. International Journal of Molecular Science, 20(13), 3296. https://doi.org/10.3390/ijms20133296CrossRef

264.

Perez-Cano, R., Vranckx, J. J., Lasso, J. M., Calabrese, C., Merck, B., Milstein, A. M., et al. (2012). Prospective trial of adipose-derived regenerative cell (ADRC)-enriched fat grafting for partial mastectomy defects: The RESTORE-2 trial. European Journal of Surgical Oncology, 38(5), 382–389. https://doi.org/10.1016/j.ejso.2012.02.178CrossRefPubMed

265.

Bircoll, M. (1987). Cosmetic breast augmentation utilizing autologous fat and liposuction techniques. Plastic and Reconstructive Surgery, 79(2), 267–271. https://doi.org/10.1097/00006534-198702000-00022CrossRefPubMed

266.

Losken, A., Pinell, X. A., Sikoro, K., Yezhelyev, M. V., Anderson, E., & Carlson, G. W. (2011). Autologous fat grafting in secondary breast reconstruction. Annals of Plastic Surgery, 66(5), 518–522. https://doi.org/10.1097/SAP.0b013e3181fe9334CrossRefPubMed

267.

Agha, R. A., Goodacre, T., & Orgill, D. P. (2013). Use of autologous fat grafting for reconstruction postmastectomy and breast conserving surgery: A systematic review protocol. British Medical Journal Open, 3(10), e003709. https://doi.org/10.1136/bmjopen-2013-003709CrossRef

268.

Gutowski, K. A. (2009). Current applications and safety of autologous fat grafts: A report of the ASPS fat graft task force. Plastic and Reconstructive Surgery, 124(1), 272–280. https://doi.org/10.1097/PRS.0b013e3181a09506CrossRefPubMed

269.

Gir, P., Oni, G., Brown, S. A., Mojallal, A., & Rohrich, R. J. (2012). Human adipose stem cells: Current clinical applications. Plastic and Reconstructive Surgery, 129(6), 1277–1290. https://doi.org/10.1097/PRS.0b013e31824ecae6CrossRefPubMed

270.

Silva-Vergara, C., Fontdevila, J., Weshahy, O., Yuste, M., Descarrega, J., & Grande, L. (2017). Breast Cancer recurrence is not increased with lipofilling reconstruction: A case-controlled study. Annals of Plastic Surgery, 79(3), 243–248. https://doi.org/10.1097/sap.0000000000001106CrossRefPubMed

271.

Toyserkani, N. M., Jørgensen, M. G., Tabatabaeifar, S., Jensen, C. H., Sheikh, S. P., & Sørensen, J. A. (2017). Concise review: A safety assessment of adipose-derived cell therapy in clinical trials: A systematic review of reported adverse events. Stem Cells Translational Medicine, 6(9), 1786–1794. https://doi.org/10.1002/sctm.17-0031CrossRefPubMedPubMedCentral

272.

Waked, K., Colle, J., Doornaert, M., Cocquyt, V., & Blondeel, P. (2017). Systematic review: The oncological safety of adipose fat transfer after breast cancer surgery. Breast, 31, 128–136. https://doi.org/10.1016/j.breast.2016.11.001CrossRefPubMed

273.

Sorrentino, L., Regolo, L., Scoccia, E., Petrolo, G., Bossi, D., Albasini, S., et al. (2019). Autologous fat transfer after breast cancer surgery: An exact-matching study on the long-term oncological safety. European Journal of Surgical Oncology, 45(10), 1827–1834. https://doi.org/10.1016/j.ejso.2019.05.013CrossRefPubMed

274.

Fang, J., Chen, F., Liu, D., Gu, F., & Wang, Y. (2021). Adipose tissue-derived stem cells in breast reconstruction: A brief review on biology and translation. Stem Cell Research & Therapy, 12(1), 8. https://doi.org/10.1186/s13287-020-01955-6CrossRef

275.

Kronowitz, S. J., Mandujano, C. C., Liu, J., Kuerer, H. M., Smith, B., Garvey, P., et al. (2016). Lipofilling of the breast does not increase the risk of recurrence of breast cancer: A matched controlled study. Plastic and Reconstructive Surgery, 137(2), 385–393. https://doi.org/10.1097/01.prs.0000475741.32563.50CrossRefPubMed

276.

Chung, J. H., Kim, K. J., Jung, S. P., Park, S. H., & Yoon, E. S. (2021). Analysis of oncological safety of autologous fat grafting after immediate breast reconstruction. Gland Surgery, 10(2), 584–594. https://doi.org/10.21037/gs-20-645CrossRefPubMedPubMedCentral

277.

De Berti, M., Goupille, C., Doucet, M., Arbion, F., Vilde, A., Body, G., et al. (2022). Oncological safety of autologous fat grafting in breast reconstruction after mastectomy for cancer: A case-control study. Journal of Gynecology Obstetrics and Human Reproduction, 51(1), 102257.CrossRef

Titel: The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer
verfasst von: Bruce A. Bunnell
Elizabeth C. Martin
Margarite D. Matossian
Courtney K. Brock
Khoa Nguyen
Bridgette Collins-Burow
Matthew E. Burow
Publikationsdatum: 24.08.2022
Verlag: Springer US
Erschienen in: Cancer and Metastasis Reviews / Ausgabe 3/2022
Print ISSN: 0167-7659
Elektronische ISSN: 1573-7233
DOI: https://doi.org/10.1007/s10555-022-10063-1

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer

Abstract

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2022

The role of obesity and bariatric surgery-induced weight loss in breast cancer

Breast cancer microenvironment and obesity: challenges for therapy

Notch signaling in malignant gliomas: supporting tumor growth and the vascular environment

Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?

Clinical interventions to break the obesity and cancer link: a narrative review

Biography—Mikhail Kolonin

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie